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INTRODUCTION: X‐linked intellectual disability (XLID) represents a common cause of 
monogenic mental retardation affecting mostly males. However it is not uncommon to have 
X‐linked disorders with variable degrees of penetrance or a skewed X‐inactivation, phenomena 
that hamper prediction of the phenotype. Based on the clinical presentation, XLID can be 
categorized into three classes: syndromes, encompassing multiple congenital anomalies 
compromising other organs beyond the brain; neuromuscular disorders presenting 
neurological and/or muscular symptoms such as epilepsy, dystonia, spasticity and muscle 
weakness in the absence of malformations; nonspecific conditions, where ID is the only 
consistent clinical sign and their discrimination depends entirely on the determination of the 
causative gene. Among the genetic causes involved, mutations in FMR1, AFF2 and ARX genes 
emerge as important causes. FMR1 and AFF2 genes contain polymorphic repetitive regions 
susceptible to suffer dynamic mutations, which may give rise to pathogenic expansions. In the 
ARX gene, the second exon represents a mutational hotspot as it contains repetitive regions 
coding for alanine stretches. Among those present in polyalanine tracts, c.429_452dup24 is the 
most frequent.  
OBJECTIVES: To characterize a population at risk for ID.  
MATERIAL AND METHODS: Aiming for the characterization of a population at risk for ID, a 
multiplex molecular screening technique was developed targeting mutational hotspots in 
FMR1, AFF2 and ARX.  
RESULTS: The assay was used to screen over 4500 intellectually‐disabled individuals.  
CONCLUSIONS: The present work represents the first retrospective study of a Portuguese 
population where Fragile‐X Syndrome was excluded, screened by this three gene cluster‐based 
approach. This method should improve the detection of genetic conditions associated with 
these three genes, which are likely to be underdiagnosed. 
